Pharmaceutical Company Rankings by Equity ratio
Compare Japanese listed companies using EDINET financial data across metrics such as revenue, margins, ROE, and growth.
For Pharmaceutical by Equity ratio, the top 5 companies are ノイルイミューン・バイオテック株式会社 (97.8%), RIBOMIC Inc. (95.4%), 株式会社Veritas In Silico (94.6%), Renascience Inc. (94.5%), Heartseed株式会社 (93.7%). 81 of 82 companies in the selected population have usable Equity ratio data. The ranking uses each company’s latest annual data; fiscal periods may differ. Companies ranked sixth and below are also shown in the ranking table below.
Compare industries by Median Equity RatioRanking metrics
※ Deposits, lending, and securities investment have a large impact on financial companies, so FCF, FCF margin, and FCF growth may not be suitable for simple comparisons with other industries.
Company ranking chart
Company ranking table
| Rank | Company | Industry | Fiscal year | Equity ratio |
|---|---|---|---|---|
| 1 | ノイルイミューン・バイオテック株式会社 | Pharmaceutical | FY2025 | 97.8% |
| 2 | RIBOMIC Inc. | Pharmaceutical | FY2026 | 95.4% |
| 3 | 株式会社Veritas In Silico | Pharmaceutical | FY2025 | 94.6% |
| 4 | Renascience Inc. | Pharmaceutical | FY2026 | 94.5% |
| 5 | Heartseed株式会社 | Pharmaceutical | FY2026 | 93.7% |
| 6 | Modalis Therapeutics Corporation | Pharmaceutical | FY2025 | 93.0% |
| 7 | 株式会社メドレックス | Pharmaceutical | FY2025 | 92.2% |
| 8 | TMS Co., Ltd | Pharmaceutical | FY2025 | 92.1% |
| 9 | Cuorips Inc. | Pharmaceutical | FY2026 | 91.6% |
| 10 | Kubota Pharmaceutical Holdings Co., Ltd. | Pharmaceutical | FY2025 | 91.6% |
Source: FSA EDINET / Data and metrics: bestforever.jp
New EDINET filings are typically imported within minutes, with financial data and analysis results updated accordingly.